Please login to the form below
France
This page shows the latest France news and features for those working in and with pharma, biotech and healthcare.
Sanofi/Regeneron’s Dupixent shows promise in atopic hand and foot dermatitis
Atopic hand and foot dermatitis can extensively disrupt the lives of patients, given the intense itch and painful skin lesions it causes on essential body areas,” explained Eric Simpson, Frances J
Latest news
-
Merck reports positive results for Keytruda combination in malignant pleural mesothelioma
The phase 2/3 CCTG IND.227/KEYNOTE-483 trial was sponsored and conducted by the Canadian Cancer Trials Group (CCTG) in collaboration with investigators in Italy and France.
-
GSK’s new global survey exposes lupus treatment gaps
HCPs were surveyed across France, Spain, Germany, Canada, China and Japan between July and September 2022.
-
Act-Accelerator outlines plans for longterm COVID-19 control
Set up in 2020, ACT-A was launched by the World Health Organization (WHO), the President of France, the President of the European Commission and the Bill &Melinda Gates Foundation, in
-
Novartis bags CHMP recommendation for prostate cancer drug Pluvicto
Commenting on the positive results, Marie-France Tschudin, president, innovative medicines international and chief commercial officer, Novartis, said: “This positive CHMP opinion for Pluvicto is an important step forward in our
-
Sanofi and NIHR enrol first patient in immunisation study for RSV in infants
Over 20, 000 infants in the UK, France and Germany will be enrolled in the trial, which will run from August 2022 to March 2023.
More from news
Approximately 25 fully matching, plus 676 partially matching documents found.
Latest Intelligence
-
The state of pharma customer experience
largest markets, despite Germany and France having largely ended their own COVID-19 restrictions by then.
-
Assessing the impact of rarity on French HTA and pricing decisions
in France, we look at how French payers have in the past valued rarity. ... An interesting example of the importance of eligible patient number in pricing negotiations in France is Kalydeco.
-
Global leaders in digital channels
compared to 28 in Italy and 18 in France). ... This low level of weekly channel activity contrasts significantly with users in Spain, who recorded a higher volume of interactions per user than in the other four major European countries (France,
-
AI: powering healthcare, empowering patients Physician perceptions of AI and the future of pharma
In partnership with Medefield, we recently ran a poll with 70 physicians including cardiologists, rheumatologists and gastroenterologists across Europe (France, Italy, Spain, Germany), the UK and the US, to gauge their
-
Diversity in Pharma: The Impact of COVID-19 on DE&I
A New Jersey native, Marsha’s career has allowed her to live and work abroad and brought her to France in 2017.
More from intelligence
Approximately 5 fully matching, plus 125 partially matching documents found.
Latest appointments
-
Ogilvy Health appoints Rebecca Carter to newly created head of social media role
Frances Cassidy who has been appointed as a senior account manager.
-
Saturnino Izquierdo takes on expanded role at McCann Health
In the new role, Izquierdo is set to lead the teams in the network’s four markets across Europe and Latin America, which includes the UK, France, Germany and Brazil.
-
3 Monkeys Zeno taps Avril Lee to lead UK and EU healthcare business
Lee will be based at 3MZ in London and will focus on expanding the agency’s healthcare work in the UK, France and Germany.
-
McCann Health France strengthens team with two new hires
In her new role at McCann Health France, Brunet will shape the creative vision and direction of McCann Healthcare Paris’ creative department. ... Prior to McCann Health France, she served as scientific director at various international health
-
RFA strengthens team with a host of hires and promotions
Finally, Gloria Kesterton has joined as an account executive. She recently graduated from Université Grenoble Alpes, France, with a joint masters degree in Molecular and Cell Biology, and Business and Marketing
More from appointments
Approximately 1 fully matching, plus 57 partially matching documents found.
Latest from PMHub
-
Medscape Medical Affairs Celebrate a Double Win at the PMEAs
The entry describes the collaboration between L’Institut Servier, Gustave Roussy (Villejuif, France), Dana-Farber Cancer Institute (Boston, USA), and Medscape Medical Affairs to establish a global community of innovators across
-
Medscape Medical Affairs are PMEA Finalists in Three Categories
Excellence in Collaboration and Partnerships. The entry describes the collaboration between L’Institut Servier, Gustave Roussy (Villejuif, France), Dana-Farber Cancer Institute (Boston, USA), and Medscape Medical Affairs to establish a
-
Viseven opens a new center of excellence in India
Presently, the company has specialists in more than ten countries, including the United States, Canada, Argentina, France, Spain, Germany, Poland, and Ukraine.
-
How do doctors want to engage with pharma on new products?
M3 Global Research put these questions to 1, 848 EU doctors mainly from the top five EU nations – Germany (332); France (380); Italy (266); Spain (293) and UK (318).
-
M3 Acquires MirVracha LCC in Russia Launching Full-Scale Development of Physician Platform Business in Russia
Presence outside of Japan includes the U.S., U.K., France, China, Korea and India, with aggressive business expansion overseas that has amassed over 6 million physicians as members across its
More from PMHub
Approximately 0 fully matching, plus 74 partially matching documents found.
Subscribe to our email news alerts
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Results for Astellas’ non-hormonal menopause drug published in The Lancet
- 2023 PM Society Awards – winners announced
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- FDA external report recommends actions to address US opioid crisis
- MHRA to introduce new UK clinical trials framework
- Sanofi/Regeneron’s Dupixent approved by EC for atopic dermatitis in children
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Inizio appoints Stefanie Christmas as global head of DE&I
- Rare diseases: not so rare after all
- Sanofi/Regeneron’s Dupixent shows promise in atopic hand and foot dermatitis
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Biogen and Eisai’s Alzheimer’s drug to be covered by US Veterans Health Administration
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Dermavant reports positive phase 3 results for Vtama cream in atopic dermatitis
- Pfizer/BioNTech’s Omicron-adapted booster approved by FDA for young children
- Havas Health & You appoints Alex Okada as chief creative officer of Havas Lynx Group
PMHub
The Good Ideas Group
Remarkable but responsible creative work. We're most passionate about the pursuit of original, powerful ideas that our clients can harness...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
